BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.170
-0.026 (-2.17%)
Jan 6, 2026, 4:00 PM EST - Market closed
BioRestorative Therapies Market Cap
BioRestorative Therapies has a market cap or net worth of $10.39 million as of January 6, 2026. Its market cap has decreased by -2.94% in one year.
Market Cap
10.39M
Enterprise Value
5.90M
1-Year Change
-2.94%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since November 5, 2021, BioRestorative Therapies's market cap has increased from $6.50M to $10.39M, an increase of 59.77%. That is a compound annual growth rate of 11.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 10.60M | 1.92% |
| Dec 31, 2025 | 10.40M | 5.05% |
| Dec 31, 2024 | 9.90M | 20.73% |
| Dec 29, 2023 | 8.20M | -18.81% |
| Dec 30, 2022 | 10.10M | -33.55% |
| Dec 31, 2021 | 15.20M | 133.85% |
| Nov 5, 2021 | 6.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.72B |
| Johnson & Johnson | 493.40B |
| AbbVie | 395.77B |
| UnitedHealth Group | 316.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.22B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |